Cargando…
Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan
In addition to headache, migraine is characterized by a series of symptoms that negatively affects the quality of life of patients. Generally, these are represented by nausea, vomiting, photophobia, phonophobia and osmophobia, with a cumulative percentage of the onset in about 90% of the patients. F...
Autores principales: | Allais, Gianni, Acuto, Giancarlo, Benedetto, Chiara, D’Andrea, Giovanni, Grazzi, Licia, Manzoni, Gian Camillo, Moschiano, Franca, d’Onofrio, Florindo, Valguarnera, Fabio, Bussone, Gennaro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869014/ https://www.ncbi.nlm.nih.gov/pubmed/20464599 http://dx.doi.org/10.1007/s10072-010-0302-9 |
Ejemplares similares
-
Almotriptan 12.5 mg in menstrually related migraine: A
randomized, double-blind, placebo-controlled study
por: Allais, Gianni, et al.
Publicado: (2011) -
Menstrual migraine
por: Moschiano, Franca, et al.
Publicado: (2001) -
Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura
por: Allais, Gianni, et al.
Publicado: (2014) -
The serotonergic system in migraine
por: Leone, Massimo, et al.
Publicado: (2001) -
Disability and migraine: MIDAS
por: D’Amico, Domenico, et al.
Publicado: (2001)